Cardiac resynchronization therapy: a comprehensive review
Jeremy Moskovitch1, Aleksandr Voskoboinik2,3,4
1Alfred Heart Centre, Alfred Hospital, Melbourne, Australia.
Insights
Cardiac resynchronization therapy (CRT) remains crucial for heart failure (HF) despite rising prevalence. This review explores current trials, indications, and emerging technologies for CRT in HF management.
Area of Science:
- Cardiology
- Medical Devices
- Heart Failure Management
Background:
- Heart failure (HF) prevalence is increasing globally.
- Medical treatments and implantable devices for HF are continuously advancing.
- Cardiac resynchronization therapy (CRT) is an established HF treatment with evolving applications.
Purpose of the Study:
- To provide a clinical perspective on cardiac resynchronization therapy (CRT) for heart failure (HF).
- To review major clinical trials, current indications, and controversies surrounding CRT.
- To discuss emerging aspects and competing technologies in CRT for HF.
Main Methods:
- Literature review of major clinical trials.
- Analysis of current clinical indications for CRT.
- Discussion of controversies and emerging technologies in CRT.
Main Results:
- Evidence for novel CRT indications is expanding.
- Optimization of lead placement and device programming are critical.
- New competing technologies are emerging in the CRT landscape.
Conclusions:
- CRT remains a vital therapy for select heart failure patients.
- Ongoing research and technological advancements are refining CRT applications.
- A comprehensive understanding of CRT trials, indications, and future directions is essential for clinicians.
Abstract:
Despite improved understanding of heart failure (HF) and advances in medical treatments, its prevalence continues to rise, and the role of implantable devices continues to evolve. While cardiac resynchronization therapy (CRT) is an accepted form of treatment for many suffering from HF, there is an ever-evolving body of evidence examining novel indications, optimization of lead placement and device programming, with several competing technologies now also on the horizon. This review aims to take a clinical perspective on the major trials, current indications, controversies and emerging aspects of CRT in the treatment of HF.
Related Concept Videos
Review and Preview
Percentiles are a type of fractile that partition data into...
Review and Preview
Gene Therapy
Group Therapy
Cardiac Output II: Effect of Stroke Volume on Cardiac Output
Preload
Preload refers to the initial elongation of the cardiac myocytes before contraction and is related to the volume of blood filling the heart at the end of diastole, or end-diastolic volume. The...
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...


